Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorVélez, Jorge I.
dc.contributor.authorLopera, Francisco
dc.contributor.authorCreagh, Penelope K.
dc.contributor.authorPiñeros, Laura B.
dc.contributor.authorDas, Debjani
dc.contributor.authorCervantes-Henríquez, Martha L.
dc.contributor.authorAcosta-López, Johan E.
dc.contributor.authorIsaza – Ruget, Mario A.
dc.contributor.authorEspinosa, Lady G.
dc.contributor.authorEasteal, Simon
dc.contributor.authorQuintero, Gustavo A.
dc.contributor.authorTamar Silva, Claudia
dc.contributor.authorMastronardi, Claudio A.
dc.contributor.authorArcos-Burgos, Mauricio
dc.description.abstractBackground: The identification of novel genetic variants contributing to the widespread in the age of onset (AOO) of Alzheimer’s disease (AD) could aid in the prognosis and/or development of new therapeutic strategies focused on early interventions. Methods: We recruited 78 individuals with AD from the Paisa genetic isolate in Antioquia, Colombia. These individuals belong to the world largest multigenerational and extended pedigree segregating AD as a consequence of a dominant fully penetrant mutation in the PSEN1 gene and exhibit an AOO ranging from the early 30s to the late 70s. To shed light on the genetic underpinning that could explain the large spread of the age of onset (AOO) of AD, 64 single nucleotide polymorphisms (SNP) associated with neuroanatomical, cardiovascular and cognitive measures in AD were genotyped. Standard quality control and filtering procedures were applied, and single- and multi-locus linear mixed-effects models were used to identify AOO associated SNPs. A full two-locus interaction model was fitted to define how identified SNPs interact to modulate AOO. Results: We identified two key epistatic interactions between the APOE*E2 allele and SNPs ASTN2-rs7852878 and SNTG1-rs16914781 that delay AOO by up to ~8 years (95%CI: 3.2-12.7, P=1.83x10-3) and ~7.6 years (95%CI: 3.3-11.8, P = 8.69x10-4), respectively, and validated our previous finding indicating that APOE*E2 delays AOO of AD in PSEN1 E280 mutation carriers. Discussion: This new evidence involving APOE*E2 as an AOO delayer could be used for developing precision medicine approaches and predictive genomics models to potentially determine AOO in individuals genetically predisposed to AD.eng
dc.sourceMolecular Neurobiologyeng
dc.sourceVol. 55, No.12035 (2018)eng
dc.subjectAlzheimer's diseaseeng
dc.subjectAge of Onseteng
dc.subjectGenetic Isolateeng
dc.subjectExtreme phenotypeseng
dc.titleTargeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer’s Diseaseeng
dcterms.bibliographicCitationBrookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimer's & Dementia. 2007;3(3):186-91.eng
dcterms.bibliographicCitationArcos-Burgos M, Muenke M. Genetics of population isolates. Clinical Genetics. 2002;61(4):233-47.eng
dcterms.bibliographicCitationAcosta-Baena N, Sepulveda-Falla D, Lopera-Gomez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study. Lancet Neurol. 2011;10(3):213-20.eng
dcterms.bibliographicCitationLopera F, Ardilla A, Martinez A, Madrigal L, Arango-Viana JC, Lemere CA, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. Jama. 1997;277(10):793-9.eng
dcterms.bibliographicCitationBravo ML, Valenzuela CY, Arcos-Burgos OM. Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia). Gene Geogr. 1996;10(1):11-7.eng
dcterms.bibliographicCitationLondono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, et al. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers. Alzheimers Dement. 2014;10(5):552-61.eng
dcterms.bibliographicCitationVelez JI, Chandrasekharappa SC, Henao E, Martinez AF, Harper U, Jones M, et al. Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease. Mol Psychiatry. 2013;18(5):568-75.eng
dcterms.bibliographicCitationVelez JI, Lopera F, Sepulveda-Falla D, Patel HR, Johar AS, Chuah A, et al. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease. Molecular psychiatry. 2016;21(7):916-24.eng
dcterms.bibliographicCitationVelez JI, Rivera D, Mastronardi CA, Patel HR, Tobon C, Villegas A, et al. A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease. Neural Plast. 2016;2016:9760314.eng
dcterms.bibliographicCitationVelez JI, Lopera F, Patel HR, Johar AS, Cai Y, Rivera D, et al. Mutations modifying sporadic Alzheimer's disease age of onset. Am J Med Genet B Neuropsychiatr Genet. 2016;171(8):1116-30.eng
dcterms.bibliographicCitationLee JH, Cheng R, Vardarajan BN, Lantigua RA, Reyes-Dumeyer D, Ortmann W, et al. SORBS2, SH3RF3, AND NPHP1 MODIFY AGE AT ONSET IN CARRIERS OF THE G206A MUTATION IN PSEN1 WITH FAMILIAL ALZHEIMER'S DISEASE. Alzheimer's & Dementia. 2014;10(4):P632.eng
dcterms.bibliographicCitationLee JH, Cheng R, Vardarajan B, Lantigua R, Reyes-Dumeyer D, Ortmann W, et al. Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics. JAMA Neurol. 2015;72(9):1043-51.eng
dcterms.bibliographicCitationChabris CF, Hebert BM, Benjamin DJ, Beauchamp J, Cesarini D, van der Loos M, et al. Most reported genetic associations with general intelligence are probably false positives. Psychol Sci. 2012;23(11):1314-23.eng
dcterms.bibliographicCitationDavies G, Tenesa A, Payton A, Yang J, Harris SE, Liewald D, et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry. 2011;16(10):996-1005.eng
dcterms.bibliographicCitationMorris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39(9):1159-65.eng
dcterms.bibliographicCitationFleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol. 2012;11(12):1057-65.eng
dcterms.bibliographicCitationReiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol. 2012;11(12):1048-56.eng
dcterms.bibliographicCitationReiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis. 2011;26 Suppl 3:321-9.eng
dcterms.bibliographicCitationPetersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8.eng
dcterms.bibliographicCitationAssociation AP. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. Association AP, editor. Washington, D.C.2000.eng
dcterms.bibliographicCitationGunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nature genetics. 2005;37(5):549-54.eng
dcterms.bibliographicCitationBansal V, Libiger O, Torkamani A, Schork NJ. Statistical analysis strategies for association studies involving rare variants. Nature reviews Genetics. 2010;11(11):773-85.eng
dcterms.bibliographicCitationLiu DJ, Leal SM. A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS genetics. 2010;6(10):e1001156.eng
dcterms.bibliographicCitationLiu DJ, Leal SM. Replication strategies for rare variant complex trait association studies via next-generation sequencing. American journal of human genetics. 2010;87(6):790-801.eng
dcterms.bibliographicCitationSegura V, Vilhjalmsson BJ, Platt A, Korte A, Seren U, Long Q, et al. An efficient multi-locus mixed-model approach for genome-wide association studies in structured populations. Nature genetics. 2012;44(7):825-30.eng
dcterms.bibliographicCitationBenjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289-300.eng
dcterms.bibliographicCitationVélez JI, Correa JC, Arcos-Burgos M. A new method for detecting significant p-values with applications to genetic data. Revista Colombiana de Estadistica. 2014;37(1):67-76.eng
dcterms.bibliographicCitationAcosta MT, Velez JI, Bustamante ML, Balog JZ, Arcos-Burgos M, Muenke M. A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome. Transl Psychiatry. 2011;1:e17.eng
dcterms.bibliographicCitationCordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11(20):2463-8.eng
dcterms.bibliographicCitationCordell HJ, Todd JA, Hill NJ, Lord CJ, Lyons PA, Peterson LB, et al. Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. Genetics. 2001;158(1):357-67.eng
dcterms.bibliographicCitationEfron B. Bootstrap Methods: Another Look at the Jacknife. The Annals of Statistics. 1979;7(1):1-26.eng
dcterms.bibliographicCitationEfron B, Tibshirani R. Bootstrap Methods for Standard Errors, Confidence Intervals and Other Measures of Statistical Accuracy. Statistical Science. 1986;1(1):54-77.eng
dcterms.bibliographicCitationLendon CL, Martinez A, Behrens IM, Kosik KS, Madrigal L, Norton J, et al. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Human mutation. 1997;10(3):186-95.eng
dcterms.bibliographicCitationPastor P, Roe CM, Villegas A, Bedoya G, Chakraverty S, Garcia G, et al. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Annals of neurology. 2003;54(2):163-9.eng
dcterms.bibliographicCitationCorder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Jr., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature genetics. 1994;7(2):180-4.eng
dcterms.bibliographicCitationBerlau DJ, Corrada MM, Head E, Kawas CH. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology. 2009;72(9):829-34.eng
dcterms.bibliographicCitationVerdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res. 2004;50(4):397-409.eng
dcterms.bibliographicCitationBrier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Science Translational Medicine. 2016;8(338):338ra66.eng
dcterms.bibliographicCitationLee HG, Casadesus G, Zhu X, Takeda A, Perry G, Smith MA. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Annals of the New York Academy of Sciences. 2004;1019:1-4.eng
dcterms.bibliographicCitationFjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB, Alzheimer's Disease Neuroimaging I. What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014;117:20-40.eng
dcterms.bibliographicCitationBateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. New England Journal of Medicine. 2012;367(9):795-804.eng
dcterms.bibliographicCitationFleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. The Lancet Neurology. 2012;11(12):1057-65.eng
dcterms.bibliographicCitationGuerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging. 2012;33(3):437-56.eng
dcterms.bibliographicCitationSun X, Chen WD, Wang YD. beta-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease. Front Pharmacol. 2015;6:221.eng
dcterms.bibliographicCitationLemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med. 1996;2(10):1146-50.eng
dcterms.bibliographicCitationSelkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behavioural brain research. 2008;192(1):106-13.eng
dcterms.bibliographicCitationCrouse NR, Ajit D, Udan ML, Nichols MR. Oligomeric amyloid-beta(1-42) induces THP-1 human monocyte adhesion and maturation. Brain research. 2009;1254:109-19.eng
dcterms.bibliographicCitationDinamarca MC, Rios JA, Inestrosa NC. Postsynaptic Receptors for Amyloid-beta Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease. Frontiers in physiology. 2012;3:464.eng
dcterms.bibliographicCitationWalker D, Lue LF, Paul G, Patel A, Sabbagh MN. Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease. Expert opinion on investigational drugs. 2015;24(3):393-9.eng
dcterms.bibliographicCitationNoble W, Hanger DP, Miller CC, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Frontiers in neurology. 2013;4:83.eng
dcterms.bibliographicCitationZempel H, Thies E, Mandelkow E, Mandelkow EM. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30(36):11938-50.eng
dcterms.bibliographicCitationBloom GS. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505-8.eng
dcterms.bibliographicCitationAmar F, Sherman MA, Rush T, Larson M, Boyle G, Chang L, et al. Amyloid-β oligomer Aβ*56 induces specific alterations of tau phosphorylation and neuronal signaling. Science signaling. 2017;10(478):eaal2021.eng
dcterms.bibliographicCitationSuri S, Heise V, Trachtenberg AJ, Mackay CE. The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2. Neurosci Biobehav Rev. 2013;37(10 Pt 2):2878-86.eng
dcterms.bibliographicCitationChalmers K, Wilcock GK, Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol. 2003;29(3):231-8.eng
dcterms.bibliographicCitationKanekiyo T, Xu H, Bu G. ApoE and Abeta in Alzheimer's disease: accidental encounters or partners? Neuron. 2014;81(4):740-54.eng
dcterms.bibliographicCitationLukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, Huber W, et al. A global map of human gene expression. Nat Biotechnol. 2010;28(4):322-4.eng
dcterms.bibliographicCitationKamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, et al. A schizophreniaassociated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol. 2005;7(12):1167-78.eng
dcterms.bibliographicCitationArcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry. 2010;15(11):1053-66.eng
dcterms.bibliographicCitationO'Sullivan ML, de Wit J, Savas JN, Comoletti D, Otto-Hitt S, Yates JR, 3rd, et al. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron. 2012;73(5):903-10.eng
dcterms.bibliographicCitationToma C, Torrico B, Hervas A, Valdes-Mas R, Tristan-Noguero A, Padillo V, et al. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry. 2014;19(7):784-90.eng
dcterms.bibliographicCitationLee BH, Kim YK. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig. 2010;7(4):231-5.eng
dcterms.bibliographicCitationBis JC, DeCarli C, Smith AV, van der Lijn F, Crivello F, Fornage M, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nature genetics. 2012;44(5):545-51.eng
dcterms.bibliographicCitationHibar DP, Adams HHH, Jahanshad N, Chauhan G, Stein JL, Hofer E, et al. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017;8:13624.eng
dcterms.bibliographicCitationVrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Genetic R, Outcome in Psychosis C, et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. American journal of human genetics. 2008;83(4):504-10.eng
dcterms.bibliographicCitationWang KS, Liu XF, Aragam N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res. 2010;124(1-3):192-9.eng
dcterms.bibliographicCitationLesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT, et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna). 2008;115(11):1573-85.eng
dcterms.bibliographicCitationWang KS, Tonarelli S, Luo X, Wang L, Su B, Zuo L, et al. Polymorphisms within ASTN2 gene are associated with age at onset of Alzheimer's disease. J Neural Transm (Vienna). 2015;122(5):701-8.eng
dcterms.bibliographicCitationHafner A, Obermajer N, Kos J. gamma-1-syntrophin mediates trafficking of gamma-enolase towards the plasma membrane and enhances its neurotrophic activity. Neurosignals. 2010;18(4):246- 58.eng
dcterms.bibliographicCitationLencz T, Lambert C, DeRosse P, Burdick KE, Morgan TV, Kane JM, et al. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci U S A. 2007;104(50):19942-7.eng
dcterms.bibliographicCitationChen BJ, Mills JD, Takenaka K, Bliim N, Halliday GM, Janitz M. Characterization of circular RNAs landscape in multiple system atrophy brain. J Neurochem. 2016;139(3):485-96.eng
dcterms.bibliographicCitationRusina R, Bourdain F, Matej R. [Multiple system atrophy and Alzheimer's disease: a case report of a rare association of two neuro-degenerative disorders]. Rev Neurol (Paris). 2007;163(12):1239-41.eng
dcterms.bibliographicCitationChen H, Cade BE, Gleason KJ, Bjonnes AC, Stilp AM, Sofer T, et al. Multiethnic Meta- Analysis Identifies RAI1 as a Possible Obstructive Sleep Apnea-related Quantitative Trait Locus in Men. American journal of respiratory cell and molecular biology. 2018;58(3):391-401.eng
dcterms.bibliographicCitationEmamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung GY, et al. The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective. Frontiers in aging neuroscience. 2016;8:78.eng
dcterms.bibliographicCitationBenaglia T, Chauveau D, Hunter DR, Young D. mixtools: An R Package for Analyzing Finite Mixture Models. Journal of Statistical Software. 2009;32(6):1-29.eng
dcterms.bibliographicCitationR Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018.eng

Ficheros en el ítem


Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem